The focus of this report was to assess the role of passive immunization using immunoglobulins derived from chicken egg yolk in protection against M. gallisepticum infection in chickens. Immunoglobulins were produced by egg yolk technology. ELISA was used to evaluate their immunoreactivity and western immunoblotting demonstrated that chicken egg yolk immunoglobulins Y (IgY) were capable of recognizing M. gallisepticum immunoreactive antigens. Administration of IgY to experimentally infected broiler chickens afforded up to 70% protection rate as confirmed by culture analyses. Challenge of IgY -treated birds with M. gallisepticum virulent strain S6 revealed significantly (P< 0.05) lower isolation prevalence in comparison to control chickens treated with IgY from mock-immunized (control) hens that received the same bacterial challenge. Additionally, M. gallisepticum culture analysis from respiratory organs demonstrated that these antibodies protected chickens in a dose-dependent pattern against M. gallisepticum infection (i.e., increasing IgY titer resulted in decreased isolation rate). These findings demonstrate that IgY obtained from hens immunized by M. gallisepticum could provide an alternative approach for treatment of M. gallisepticum infection in chickens.
Introduction
Mycoplasma gallisepticum remains the most frequently reported bacterial causative agent of chronic respiratory disease in chickens and infectious sinusitis in turkeys (Yoder, 1991; Ley and Yoder, 1997) . In addition t o condemnation of the infected flocks M. gallisepticum infection causes reduced feed conversion and egg production, resulting in serious economic losses (Ley and Yoder, 1997; Levisohn and Kleven, 2000) . Therefore, protection against M. gallisepticum infection is of great interest to the commercial poultry breeders. Traditionally, control of M. gallisepticum has been based on eradication of the microbe from breeder flocks and on maintenance of the mycoplasma-free status in the breeders and breeder progeny by biosecurity of the premises (Levisohn and Kleven, 2000) . Efforts to reduce the adverse affects of the disease on breeders i n complexes also included the use of antibiotics and vaccines. Although useful, these efforts have not been successful in eliminating infection and shed (Kleven, 1986; Yagihashi et al., 1986; Noormohammadi et al., 2002; Reinhardt et al., 2005) . Tremendous efforts have been done to evaluate numerous therapeutic regimens for eradication of M. gallisepticum infections. However, the continued presence and increasing incidence of M. gallisepticum in c ommercial poultry farms suggests that efforts a t eradication were not highly successful. Indeed, M. gallisepticum has made a staggering comeback for a variety of reasons, including reemergence of M. gallisepticum outbreaks among poultry due to the practice of placing large poultry populations in small geographical areas under poor sanitary conditions, the increased use of live M. gallisepticum vaccines, the detection of M. gallisepticum in game and free-flying songbirds, and development of resistance against some existing antibiotics (Kleven, 1977 (Kleven, , 2003 . As a consequence, M. gallisepticum infection in the poultry industry will likely continue and limiting losses will be the primary goal. Hence, it is important to seek new, safe and effective therapies for a wider means of treating, suppressing, or preventing M gallisepticum infection. Passive immunization via the administration of pathogen specific antibodies to the bird prior to or after exposure to the organism is one of the alternative strategies that were almost entirely over looked with the introduction of antibiotics. The use of egg yolk antibodies (immunoglobulin Y (IgY)) in biomedical research is now gaining interest again due to many advantages associated with IgY (Kovacs-Nolan and Mine, 2004; Schuijffel et al., 2005) . Passive immunization with IgY has been used to prevent a variety of infections such as those caused by Salmonella enterica serovar control immunogen. Six weeks later, chickens were Typhimurium (Sunwoo et al., 1996) , enterotoxigenic received one subsequent booster injection with the Escherichia coli (Marquardt et al., 1999) , rotavirus same antigen concentration in Freund's incomplete (Sarker et al., 2001) , and Birnavirus (Malik et al., 2006) . adjuvant (1: 1). One week later after the final booster, However, despite being a convenient source o f eggs were collected daily for up to 1 month and stored at antibodies, there has been no report so far on the use of 4 C until antibody extraction. IgY in the prevention and treatment of M. gallisepticum infection.
Isolation and purification of IgY: Isolation of IgY was In this report, the therapeutic activity of IgY against M.
carried out by the dextran sulphate precipitation method gallisepticum infection in chicken was investigated. The as described (Akita and Nakai, 1993) . Briefly, egg yolk study demonstrated that IgY prepared from egg yolk of was carefully separated from the egg white and the yolk hens immunized with M. gallisepticum is effective in the membrane with forceps. The yolk preparation was mixed treatment of M. gallisepticum infections. Unraveling of with 4 volumes of Tris-buffered saline (TBS). The mixture the protective immunity acquired during M. gallisepticum was centrifuged at 1,500g for 20 min at room infection may contribute to development of effective temperature (R.T.). A 120-µl of dextran sulphate solution control strategies.
per ml of sediment were added, mixed well and (Ley and Yoder, 1997; Levisohn and Kleven, 2000) . Mycoplasma-free chickens were only included in this study. The Institutional Animal Care and Use Committee approved all described procedures.
Materials and Methods

Growth and maintenance of
Immunization procedure: For the preparation of chicken egg yolk anti-M. gallisepticum F strain Ig, five-month-old chickens were used. Chickens were divided into two groups: first group were immunized intramuscularly in the breast muscle. Each bird was injected with 1 ml (1 x 10 colony forming unit (CFU)) of M. and centrifuged at 5000 rpm for 20 min. Supernatant was discarded and the sediment was resuspended in 10 ml TBS. The solution was then centrifuged at 5000 rpm for 20 min and the supernatant was stirred and 8 ml 36% (W/V) Na SO was added and the solution was let 2 4
to stand for 30 min and centrifuged as before. The supernatant was discarded and the sediment was resuspended in 5 ml TBS buffer. The sediment, which contains the water-soluble immunoglobulin rich fraction was collected and stored at -20ºC until use.
Titration of antibodies by ELISA:
To assess the IgY titer against the challenge strain of M. gallisepticum, the enzyme-linked immunosorbent assay (ELISA) was performed. M. gallisepticum whole-cell lysate antigens were prepared by ultrasonication of broth-cultivated organisms. Briefly, M. gallisepticum F strain was harvested by centrifugation at 1,200g for 10 min, suspended in phosphate-buffered saline solution (PBSS, pH 7.0) and disrupted by sonication. Cellular material was removed by centrifugation and the supernatant was collected (M. gallisepticum whole-cell lysate). Flat-bottomed ninety-six-well plates (Flow Laboratories, McLean, Va., USA) were coated with a 100 µl of solution of the M. gallisepticum whole-cell lysate antigen (50 µg/well) in 0.05M carbonate buffer (pH 9.6) at R.T. overnight. The plate was washed three times using PBS-Tween 20, then the free binding sites were blocked by 200 µl/well of 0.2% nonfat powdered milk in coating buffer for 1 h at R.T. and then, plate was washed three times with PBS-T20. After blocking of the wells, 50 commercial breeding flock were used to evaluate the µl of egg yolk antibodies were added to the wells using protective efficacy of antibody to exposure to M. eight serial two-fold dilutions, starting at 1000 µg/ml and gallisepticum. Twenty chicks were used as negative incubated at 37 C for 3 h; the plate was then washed as controls for confirmation of Mycoplasma-free status. o mentioned before. A 50-µl of alkaline phosphatase Chickens in this group were inoculated with sterile conjugated goat anti-chicken IgY (Sigma-Aldrich, MO, Mycoplasma-free broth medium. Additionally, chicks (n USA) at dilution of 1:500 in conjugate buffer was added = 140) were infected with 100 µl containing 3×10 CFU to each well. The plate was incubated for 1 h at 37 C. For of M. gallisepticum S6 strain suspended in Difco PPLO o development of the color reaction the plates were broth. The challenge inoculum was inoculated into the incubated with 50 µ1/well of freshly prepared P-NPP in posterior air sac of passively immunized birds by using substrate buffer at 37 C. After incubation for 30 min, the a MicroAliquator (Scientific Manufacturing Industries). o reaction was stopped by addition of 25 µ1/well stopper One day post infection, M. gallisepticum -infected solution (3 M NaOH). The absorbance was measured at chickens were randomly divided into seven experimental 405 nm using a microplate reader (Bio TEK, VT, USA).
groups (n = 20/group) as follows: (i) M. gallisepticum Controls for this assay comprised sera from M.
infection only and served as a positive control, (ii) gallisepticum infected chickens as positive control and treatment with 7 µg of IgY /ml and (iii) treatment with 15 from non-infected chickens as negative control. Test µg of IgY/ml, (iv) treatment with 31 µg of IgY/ml. Egg yolk groups included sera from passively immunized antibodies were administered intraperitoneally daily for chickens against experimental M. gallisepticum seven days (i.e., groups ii, iii and iv were injected 7 times infection. Experiment was conducted in triplicates.
with 1 ml solution containing 7, 15 and 31 µg IgY,
Electrophoresis and western immunoblotting:
In order yolk antibodies dilutions that had immunoreactivity to M. to determine the specificity of produced egg yolk gallisepticum whole-cell lysate antigen compared t o antibodies against M. gallisepticum, sodium dodecyl control antibodies. (v to vii) groups were administered an sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) identical amount of the same three different was performed. Whole-cell preparations of M.
concentrations of egg yolk antibodies but from adjuvantgallisepticum S6 strain used in this study was immunized chickens (control immunogen). All groups suspended at a protein concentration of 1mg/ml in SDSwere housed in separate rooms with absolute filters on PAGE lysis buffer (50 mM Tris-HCl (pH 6.8), 2% SDS, in and outlet of ventilation to prevent infection from 10% (vol/vol), 2% beta-mercaptoethanol, 0.1% control chickens to IgY treated chicken. bromophenol blue), heated in a boiling water bath for 3 min, and stored at -20 C until used. Mycoplasma Evaluation of efficacy of immunization: Evaluation of o proteins were separated by SDS-10% PAGE and the gel protective capacity of IgY was carried out in chicken was electrophoretically transferred to nitrocellulose challenged with live virulent strain S6 of M. gallisepticum membrane filters (0.45-µm-pore size; Sigma-Aldrich, followed by IgY administration seven times at 24 h USA) for immunoblotting as described (Tsang et al., intervals, with the first dose administered 24 h after 1983). Western blot was blocked with blocking buffer infection; Birds were sacrificed one week after last (5% w/v instant nonfat milk powder in PBS) and immunization dose and swabs were taken from lung, incubated for 1 h with the polyclonal anti-M . trachea, and air sac. The colonization of M. gallisepticum gallisepticum primary IgY in blocking buffer. The in the respiratory organs in chickens was evaluated by membranes were washed three times with TBS (pH 7.4) culturing respiratory swabs taken at the time of necropsy for 5 minutes and subsequently incubated with alkaline of all chickens. All steps were carried out under sterile phosphatase-coupled rabbit anti-chicken antibodies for conditions including oropharengeal swabs from living 2 h. For M. gallisepticum protein detection, the blots were chickens. At each sampling time, tracheal swab then soaked in alkaline phosphatase substrate samples were obtained from chickens for isolation and BCIP/NBT system. The color reaction was observed phenotypic analysis of M. gallisepticum. Swabs were within 5 min and then the reaction was stopped after cultivated in Bacto-PPLO Mycoplasma broth for color formation by dipping the blots in distilled water.
enrichment. This is an essential step in cultivation from The blots were then air dried and kept in dark.
samples that contain a potential inhibitor (antibodies). Prestained SDS-PAGE standard (Bio-Rad Laboratories, Then, prevalence of M. gallisepticum was estimated by USA) was used as molecular weight markers. All steps direct plating of inoculated broth culture onto M. were carried out at R.T.
gallisepticum selective agar and incubating the plates in Passive immunization with IgY against M. agar surfaces were thereafter observed with an inverted gallisepticum infection in chickens: Eighty one-day-old microscope (Leitz) for the presence of colonies with a broiler chickens from a mycoplasma-free local fried-egg appearance after 48 hours incubation and then 7 respectively). 7, 15 and 31µg IgY were the highest egg a humidified incubator at 37 C in 5 % CO /95% air. The o 2
Every other day up to 10 days. The resulting colonies chickens to F strain immunogen and egg yolk-derived were identified as M. gallisepticum by microscopy antibodies of adjuvant-immunized chicken. Antibodies and biochemical analysis of Glucose fermentation and obtained from hens injected with adjuvant was used as Arginine deamination activities. Briefly, for glucose a control and reacted with 74, 88, 94 and 96 KDa. On the fermentation test, 2.9 ml of glucose mediaum was other hand, IgY from immunized chicken recognized added to 0.1 ml of suspected Mycoplasma culture, multiple bands with molecular sizes (M ) 31, 36, 39, 44, incubated at 37 C and examined daily for 7 days before 74, 88, 94, and 96 kDa protein from a M. gallisepticum o final conclusion was taken. Change of color from orange S6 strain lysate (Fig. 2) . Additionally, bands 74, 88, 94 to yellow indicates positive result while no color change and 96 kDa were more distinct when treated with indicates negative results. For Arginine deamination polyclonal IgY from immunized chicken compared to test, 0.1 ml of the suspected viable Mycoplasma culture those treated with polyclonal IgY of adjuvant-immunized was inoculated into 2.9 ml of the medium and incubated chicken. These data demonstrated strong cross aerobically at 37 C for 7 days, together with a n reactivity between the S6 strain antigens and o uninoculated control tubes. Change of color from violet heterologus F strain antibodies. These antibodies to dark red or reddish violet coloration indicates positive.
recognized most peptide bands from heterologus strain (Fig.  1) . Secondly, immunoreactivity of IgY derived from chicken immunized with whole M. gallisepticum F strain was evaluated by western immunoblotting. SDS-PAGE showed differences on protein banding patterns when probed with polyclonal IgY derived from egg yolk of r S6. Also, the IgY was a valuable tool for the identification strain antigens were effective as an immuno therapeutic agent in chickens when passive therapy was initiated 24 h after live S6 bacterial challenge. Anti-M. gallisepticum egg yolk antibodies at three different concentrations as determined by ELISA conferred dose-dependent protection against infection with M. gallisepticum heterologus strain S6. A high dose (15 and 31 µg/ml) of IgY treatment decreased M. gallisepticum-isolation from respiratory organs' swaps. However, the group that was administered lower dose (7 µg/ml) of IgY failed to protect chickens from M. gallisepticum infection and showed statistically non-significant difference with the M. gallisepticum infection group (P<0.3). With increased IgY titer, isolation rates decreased; birds immunized with 7 µg/ml had a prevalence of 80% positive, 53.3% o f chickens immunized with 15 µg/ml birds were positive, and 33.3% of birds immunized with 31 µg/ml birds were positive for M. gallisepticum. Also, data in Table 1 shows that isolation rates varied with the immunization status; with immunized chicken, the prevalence ranged from 30 -90%. In the adjuvantimmunized chicken the prevalence was = 70% and no significant differences were noted for the protective effect of the different concentrations of control antibodies that do not contain specific antibodies. No mortality was recorded in chicken of all tested groups till the end of the study. However, all chickens from which bacteria were It is well known that the adhesion of M. gallisepticum to its host target cell is a crucial, initial step for the establishment of the disease. Therefore, since M. gallisepticum infection is initially a respiratory infection, the choice of intraperitoneal route for IgY inoculation might not be the best presentation. However, it is at some stage transiently systemic. Subsequent to the colonization of the respiratory tract, M. gallisepticum translocates across the respiratory mucosal barrier, enter the bloodstream and progress to systemic infection throughout diverse body sites of infected birds (Lamas da Silva and Adler, 1969; Bencina and Dorrer, 1984; Soeripto et al., 1989; Chin et al., 1991; Simecka et al., 1992) . Passive transfer of M. gallisepticum -specific IgY to the mucosal surfaces of birds following pathogen challenge might have thwarted the invasion o f pathogens into the cells. Thus, by binding to a pathogen, systemically delivered antibodies inhibited pathogens from widespread colonization of host cells. Therefore, the therapeutic value of IgY against the experimental infection in chicken perhaps lies in its ability to inhibit the bacterial organism colonization. However, the relationship between inhibitions of bacterial activity and adhesion properties needs to be clarified. In conclusion, the present study investigated the efficacy of IgY against M. gallisepticum infection in a controlled trial in chickens. However, possibilities of passive immunization via intraperitoneal injection under practical conditions in big chicken farms would have to be tested. If M. gallisepticum -specific IgY used as the sole agent in preventing or treating Mycoplasmosis in chickens, affected broiler breeder flocks should be immunized with IgY prior to onset of infection in order to increase the protection rate. Even though M. gallisepticum is one of the major health problems facing the poultry industry throughout the world, the results of this study indicate that IgY derived from eggs of hens immunized by M. management of M. gallisepticum infections in chickens. However, in order to reduce losses due to adverse affects of M. gallisepticum, IgY should be integrated in combination with other established means of prevention such as sound biosecurity programs.
